US.TMO · Thermo Fisher Scientific

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.8,
      "details": {
        "atrPct": 2.513741718642522,
        "turnoverUsdM": 1088.07806086261,
        "liquidityPoints": 0.8,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.TMO",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 579.1614,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2.5,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.2,
      "stop_loss_percent": 5,
      "take_profit_price": 646.2271,
      "target_multiplier": 1.9,
      "technical_strength": 1.88,
      "take_profit_percent": 6
    },
    "positionPoints": 1.8,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.027483437285044,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 62.1,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 55.1,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 7
  },
  "market": {
    "ma20": 612.837,
    "ma50": 578.485,
    "close": 609.82,
    "prevClose": 603.18,
    "avgVolume20": 1676068,
    "volumeRatio": 1.06,
    "changePercent": 1.1
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 7,
    "details": {
      "ret_5d": -0.013922319646885062,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 7,
      "vcp_bonus": 2,
      "vol_ratio": 1.0753289097012542,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.6141616648455606,
      "volat_points": 0,
      "day_range_pct": 0.014905988407956625,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 62.1,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.9,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 58,
        "contribution": 2.9
      },
      {
        "raw": 9.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 46,
        "contribution": 9.2
      },
      {
        "raw": 7.4,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 49.33,
        "contribution": 7.4
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 70,
        "contribution": 7
      },
      {
        "raw": 18.6,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 62,
        "contribution": 18.6
      },
      {
        "raw": 8,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 80,
        "contribution": 8
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "觀望",
    "result": 55.1,
    "details": [
      "基本面分析總分: 2.9/5分",
      "資金流分析總分: 9.2/20分",
      "市場環境分析總分: 7.4/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7/10分",
      "技術信號分析總分: 18.6/30分",
      "情緒分析: 8/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.9,
      "資金流": 9.2,
      "市場環境": 7.4,
      "情緒分析": 8,
      "技術信號": 18.6,
      "風險管理": 7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0.4,
          "turnoverUsdM": 1088.07806086261,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 1.6,
          "obvPoints": 1.6,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.TMO",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.513741718642522,
          "atrPoints": 3,
          "cciPoints": 1.6,
          "vixPoints": 0,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "優秀",
        "items": {
          "sentiment": {
            "score": 8,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 6,
              "sentimentScoreRaw": 1.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141758752,
                "url": "https://finnhub.io/api/news?id=ba75c77fa5780b8ea3a539eaefb00b558fa5d93291d4d4ec48087c60130fc18b",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) shows a strong technical breakout setup with 9/10 ratings for trend and consolidation, near support with limited risk.",
                "category": "company",
                "datetime": 1788768660,
                "headline": "Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup"
              },
              {
                "id": 141437420,
                "url": "https://finnhub.io/api/news?id=42a6c5782fcd1f35ce7f5c57ba67947fe690e2e379690224565a6e17127d1191",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.",
                "category": "company",
                "datetime": 1788532500,
                "headline": "Should You Continue to Hold TMO Stock in Your Portfolio?"
              },
              {
                "id": 141424376,
                "url": "https://finnhub.io/api/news?id=86e0f4574c7139299776a663b91cb6f8394cc9180fc796f79b12c17a02026d81",
                "image": "",
                "source": "Fintel",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1788524214,
                "headline": "CLSA Initiates Coverage of Thermo Fisher Scientific (TMO) at Outperform"
              },
              {
                "id": 141369923,
                "url": "https://finnhub.io/api/news?id=d20150bde1d5a8b91aad361c7db866908d6a8a048c96121942c0ec6ae89711ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.",
                "category": "company",
                "datetime": 1788290940,
                "headline": "TMO Stock Could Gain Following the Launch of EMPAD G2 Detector"
              },
              {
                "id": 141361455,
                "url": "https://finnhub.io/api/news?id=76eedefd000e69c51d8dd08832b5cf504b0566ff29ec9a902273e5e6de09fc9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced...",
                "category": "company",
                "datetime": 1788221221,
                "headline": "Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis"
              },
              {
                "id": 141302750,
                "url": "https://finnhub.io/api/news?id=6572a92e3e41bdcd5edabcb05d4a978b7585b43adaaadc5c9d7187199fbb50a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative. See our latest analysis for Thermo Fisher Scientific. The proteomics update arrives after a strong run in Thermo Fisher Scientific’s stock, with the share price at US$629.27 and a 30 day share price return of 19.53%, alongside a 1 year total shareholder return of 26.32% that...",
                "category": "company",
                "datetime": 1787414965,
                "headline": "Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress"
              },
              {
                "id": 141302748,
                "url": "https://finnhub.io/api/news?id=6dc24ddc63a284560a6e135de26c28cab8b112bf858eb204f1d48a72a995f222",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The latest analyst work on Thermo Fisher Scientific includes a higher Fair Value Estimate that has moved from US$590.77 to US$631.42, a change of about 6.9% that feeds directly into refreshed price targets across coverage. This shift sits against a backdrop of mixed optimism and caution, as analysts weigh Q2 strength, sector updates through 2026, and the balance of growth ambition and execution risks. As you read on, you will see how this evolving narrative could shape the way you track...",
                "category": "company",
                "datetime": 1787407764,
                "headline": "Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions"
              },
              {
                "id": 141302749,
                "url": "https://finnhub.io/api/news?id=f91451998441d418cc2d9aa60636d8b22e4d0e55fe36b0b064b2e35c8431fe12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a level that is close to the current price, while market multiples lean richer. Over the past 12 months Thermo Fisher Scientific has returned 26.3%, which puts more pressure on today’s buyers to justify paying up at current levels. Participation in areas such as protein design...",
                "category": "company",
                "datetime": 1787404093,
                "headline": "Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale"
              }
            ],
            "raw_source": [
              {
                "id": 142091220,
                "url": "https://finnhub.io/api/news?id=3b25c7758098d2e2e83b4a3df7b4ca76db0ada28ba2f63fcd051f9886485f820",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Read this week's dividend recap for Dividend Champions, Contenders & Challengers—track dividend changes, upcoming ex-dividend dates & pay dates.",
                "category": "company",
                "datetime": 1789150194,
                "headline": "Dividend Champion, Contender, And Challenger Highlights: Week September 13"
              },
              {
                "id": 142077790,
                "url": "https://finnhub.io/api/news?id=5438e621f219194baa1d15e7fcb042fb457a38175e06217a807e7539eaec7fc8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global Advanced Bioreactor Systems Market is projected to grow from USD 4.2 billion in 2026 to USD 11.8 billion by 2036, at a CAGR of 10.9%. Growth is driven by biologics manufacturing, cell and gene therapies, single-use bioreactors, continuous bioprocessing, and AI-based process control. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes market segments, regional opportunities, technology trends, and key companies including Sartorius, Thermo",
                "category": "company",
                "datetime": 1789114140,
                "headline": "Advanced Bioreactor Systems Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036)"
              },
              {
                "id": 142057381,
                "url": "https://finnhub.io/api/news?id=c3c80d0da16dda8b4253cd76e11a7bd9ad834b65aaa6c44ac2560c53ca6cf082",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker development, single-cell and spatial transcriptomics, long-read RNA sequencing, and AI-powered analytics. Consumables, bulk RNA-seq, drug discovery applications, and pharmaceutical and biotechnology companies led the market in 2025. North America held the largest regional share",
                "category": "company",
                "datetime": 1789038180,
                "headline": "Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead"
              },
              {
                "id": 142058115,
                "url": "https://finnhub.io/api/news?id=c0980c35a669aef18d782de853267cf5f121f46b4fa74e056ccf223911e69c98",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global organoid intelligence market is projected to grow from USD 78.6 million in 2026 to USD 865.3 million by 2036, at a 27.1% CAGR. Growth is driven by advances in brain organoids, biological and biohybrid computing, stem cell engineering, AI, brain-on-a-chip systems, drug discovery and disease modeling. North America leads the market, while Asia-Pacific is expected to grow fastest. The report analyzes platforms, software, technologies, applications, end users, regional trends and key comp",
                "category": "company",
                "datetime": 1789038120,
                "headline": "Organoid Intelligence Market - Global Forecast to 2036; Biological Computing and Brain Organoids Drive Growth"
              },
              {
                "id": 142061219,
                "url": "https://finnhub.io/api/news?id=1d79f034a887efa00e78d5cf831f6878bcfcdc3167661eb1ca00427b8d023ef2",
                "image": "https://cdn.benzinga.com/files/images/story/2026/09/10/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "CNBC’s final trades: INFL, Wells Fargo, Nutrien and Thermo Fisher. Wells Fargo beat Q2 estimates; Nutrien missed earnings but topped sales.",
                "category": "company",
                "datetime": 1789025826,
                "headline": "Thermo Fisher, Wells Fargo, Nutrien And More On CNBC’s ‘Final Trades’"
              },
              {
                "id": 142027414,
                "url": "https://finnhub.io/api/news?id=f0d2402130489b10f71517e049005a0a2b7299da1fbec991faf3476fc4808d3f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) and Danaher (DHR) are likely to return to mid-single-digit organic re",
                "category": "company",
                "datetime": 1788976546,
                "headline": "Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says"
              },
              {
                "id": 142024707,
                "url": "https://finnhub.io/api/news?id=6ddf0f41f1d6437c138acf209a8f0bd17a53be689818cb41dff1eae7fba8d6a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1788961876,
                "headline": "Uber initiated, Thermo Fisher upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 140499175,
                "url": "https://finnhub.io/api/news?id=dfcc5f291a1f12b31d66152cdbf8f54d1ee458d3d8c0edad85206bfdf7cdbc33",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1788961876,
                "headline": "Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls"
              },
              {
                "id": 139976452,
                "url": "https://finnhub.io/api/news?id=6083dd6d61759e5dbdbb6825ce147396d95eacdb295cadd6be76044b05c6eb1f",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1788958921,
                "headline": "Shares of fertilizer companies are trading lower after Iran signaled that the Strait of Hormuz will remain open for the duration of the ceasefire, easing concerns over supply disruptions."
              },
              {
                "id": 142024766,
                "url": "https://finnhub.io/api/news?id=4ed3098578264b5c1f991234fe26fdb4e066a97af54922183394f9605241adf3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.",
                "category": "company",
                "datetime": 1788955603,
                "headline": "Here Are Tuesday’s Top Wall Street Analyst Research Calls: Abercrombie & Fitch, Affirm Holdings, Eagle Materials, Klarna Group, Martin Marietta Materials, Oklo, Qualcomm, Robinhood Markets, Ulta Beauty, and More"
              },
              {
                "id": 142030070,
                "url": "https://finnhub.io/api/news?id=3f0176b1e0120237e73032e2cd9239bec130a826c44bcd4f4c67ab7a7d77500a",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "UBS  analyst Doug Schenkel   assumes Thermo Fisher Scientific (NYSE:TMO) with a Buy rating and raises Price Target to $730.",
                "category": "company",
                "datetime": 1788946269,
                "headline": "UBS Assumes Thermo Fisher Scientific at Buy, Raises Price Target to $730"
              },
              {
                "id": 141953788,
                "url": "https://finnhub.io/api/news?id=dddaf795f9e9e73cddfc19f508575f5637f8aab85261019519c504a89f3a4189",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "A gene sequencing leader is on a powerful run fueled by real business quality, forcing investors to decide if the engine has more power than the price tag already reflects.",
                "category": "company",
                "datetime": 1788896244,
                "headline": "ILMN Stock Keeps Climbing. Should You Climb On?"
              },
              {
                "id": 141952631,
                "url": "https://finnhub.io/api/news?id=2aad58f6f5957c3b675112338c8e1c08eba3eeb93ef51f21b69c3b86297f6337",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "More than 15 distributors and procurement platforms are aligning around independently verified product sustainability data as new rules reshape environmental claims across the laboratory supply chainSAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- My Green Lab® today announced that more than 15 laboratory product distributors, procurement platforms, and laboratory analytics platforms have joined its ACT® Ecolabel Channel Partner network, expanding access to independently verified sustainability inf",
                "category": "company",
                "datetime": 1788889860,
                "headline": "My Green Lab Expands ACT Ecolabel Channel Partner Network Ahead of New EU Environmental Claims Rules"
              },
              {
                "id": 141950369,
                "url": "https://finnhub.io/api/news?id=19c57773f73e2bcf263051ee5361e187c592ab174ccf8ef44d9178907457e7d7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "150-Page Report Forecasts Market Growth from $8.50B (2025) to $18.50B by 2034, Profiling Roche, Abbott, Siemens Healthineers, Thermo Fisher, Labcorp, and 5 Other Key PlayersDublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The \"Blood Based Biomarkers - Market Insights, Competitive Landscape, and Market Forecast - 2034\" has been added to ResearchAndMarkets.com's offering. Blood Based Biomarkers Market Projected to Reach USD 18.50 Billion by 2034 The global blood based biomarkers market is estimated at U",
                "category": "company",
                "datetime": 1788882720,
                "headline": "Blood Based Biomarkers Market Report Now Available — See Why the First FDA-Cleared Alzheimer's Blood Test Just Redrew the Competitive Map"
              },
              {
                "id": 141950370,
                "url": "https://finnhub.io/api/news?id=77a8207663fc3531bd07f43e6679a684f7fd799727b1a87417a0f95a0264f960",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "578-Page Report Forecasts Market Growth from $3.18B (2026) to $5.7B by 2031, Profiling 10x Genomics, Thermo Fisher, Illumina, Oxford Nanopore, Bruker, and 14 Other Key Players Multiomics Market Multiomics Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The \"Multiomics Market by Offerings, Method, Technology, Workflow, Application, Competition - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's offering. Global Multiomics Market to Reach USD 5.70 Billion by 2031, Driven by Pre",
                "category": "company",
                "datetime": 1788882660,
                "headline": "Multiomics Market Report Now Available — See Why Spatial Omics Is Set to Outgrow Single-Cell as the Field's Next Growth Driver"
              },
              {
                "id": 141950366,
                "url": "https://finnhub.io/api/news?id=9ffbefa46ae6a3e4ca32751051e8d41fdf4e5c7ea74772461a6e2e856ea0ded6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "500-Page Report Spans 450 Data Tables Across Product, Species, Host Cell, and Application Segments as Human Recombinant Proteins Lead Demand Research Use Recombinant Protein Market Research Use Recombinant Protein Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The \"Research Use Recombinant Protein Market by Product, Product Formulation, Species, Host Cell, Application, End User, Region - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's offering. Research Use Recombinant Pro",
                "category": "company",
                "datetime": 1788878940,
                "headline": "Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $1.55B by 2031, Profiling Thermo Fisher, Bio-Techne, Merck KGaA, Danaher, Revvity, and Others"
              },
              {
                "id": 141953349,
                "url": "https://finnhub.io/api/news?id=2aa9e0f65ffce6f777325a41c31e957f88752ca2042d00725562b72134d93f2f",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_4.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 4.35% on an annualized basis producing an average annual return of 17.57%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1788868828,
                "headline": "If You Invested $1000 In Thermo Fisher Scientific Stock 15 Years Ago, You Would Have This Much Today"
              },
              {
                "id": 141950367,
                "url": "https://finnhub.io/api/news?id=445fc92e3c1cf6b5041d2d8c3fd8d2db9d8a861f9f05c8c886fb1c26da86d5de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "500-Page Report Ranks Suppliers by Competitive Position Across the Company Evaluation Matrix as Infectious Disease Testing Drives the Largest Application Segment IVD Raw Material Market IVD Raw Material Market Dublin, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The \"IVD Raw Material Market by Product Type, Technology, Application, Supply Source, Origin, End User - Global Forecast to 2031\" has been added to ResearchAndMarkets.com's offering. The global in vitro diagnostics (IVD) raw material market is pro",
                "category": "company",
                "datetime": 1788868080,
                "headline": "IVD Raw Material Market Report Now Available — Forecasts Market Growth from $21.5B (2026) to $31.1B by 2031, Profiling Merck KGaA, Thermo Fisher, Bio-Techne, Fapon Biotech, and 21 Other Key Players"
              },
              {
                "id": 141913510,
                "url": "https://finnhub.io/api/news?id=93030636154aeb4442631985be95aeeb84233bfcad77a6092698cf29fcc0784c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2238217382/image_2238217382.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation.",
                "category": "company",
                "datetime": 1788848276,
                "headline": "Health Care's Next Act: Tailwinds Emerging Across R&D Cycle"
              },
              {
                "id": 141851706,
                "url": "https://finnhub.io/api/news?id=e413e90e076e239fa7d446b88ee4c8a74c9a527007c64decee8a38d8aa618a3c",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1499635702/image_1499635702.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Baron Durable Advantage Fund reports long-term outperformance led by semiconductor and AI infrastructure leaders. Read the full analysis for more details.",
                "category": "company",
                "datetime": 1788839400,
                "headline": "Baron Durable Advantage Fund Q2 2026 Top Contributors And Detractors"
              },
              {
                "id": 141761724,
                "url": "https://finnhub.io/api/news?id=a8fa921d95061a67c4b72802ff875abd2872f04af395ac79c84b3b456a873744",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "249-Page Report Delivers Country-by-Country Forecasts Across 15 Markets, Competitive Profiles of 32 Companies, and the Investment-Grade Data You Need to Act With ConfidenceDublin, Sept. 07, 2026 (GLOBE NEWSWIRE) -- The \"Veterinary Diagnostic Markets. Strategy & Trends with Forecasts by Assay Type, by Animal, by Application, by Place, by Product, and by Country 2026 to 2030\" report has been added to ResearchAndMarkets.com's offering. The Veterinary Diagnostics industry is on a strong growth path",
                "category": "company",
                "datetime": 1788777480,
                "headline": "Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030"
              },
              {
                "id": 141758752,
                "url": "https://finnhub.io/api/news?id=ba75c77fa5780b8ea3a539eaefb00b558fa5d93291d4d4ec48087c60130fc18b",
                "image": "https://www.chartmill.com/images/uploads/CM_Breakout_Stocks_Small_free_bb09e243c7.webp",
                "source": "ChartMill",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) shows a strong technical breakout setup with 9/10 ratings for trend and consolidation, near support with limited risk.",
                "category": "company",
                "datetime": 1788768660,
                "headline": "Thermo Fisher Scientific (NYSE:TMO) Shows Strong Technical Breakout Setup"
              },
              {
                "id": 141431610,
                "url": "https://finnhub.io/api/news?id=3569d0f0c5b553b313e912c35049c367cc8408f3c8f0edd94c3b079d29162a9e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls, or Social Security decisions.",
                "category": "company",
                "datetime": 1788532532,
                "headline": "‘Corporate America Is Basically Exterminating Your Career.” Clark Howard’s Sounds Alarm For Americans In Their 50s, Who Want To Work Till 65"
              },
              {
                "id": 141437420,
                "url": "https://finnhub.io/api/news?id=42a6c5782fcd1f35ce7f5c57ba67947fe690e2e379690224565a6e17127d1191",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.",
                "category": "company",
                "datetime": 1788532500,
                "headline": "Should You Continue to Hold TMO Stock in Your Portfolio?"
              },
              {
                "id": 141424376,
                "url": "https://finnhub.io/api/news?id=86e0f4574c7139299776a663b91cb6f8394cc9180fc796f79b12c17a02026d81",
                "image": "",
                "source": "Fintel",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1788524214,
                "headline": "CLSA Initiates Coverage of Thermo Fisher Scientific (TMO) at Outperform"
              },
              {
                "id": 141416649,
                "url": "https://finnhub.io/api/news?id=6f4a40c82a75a5e5ed14adc698399c8586c8126747672004d2e4913f465953d8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 23.2% over the past six months, topping the S&P 500 by 11.5 percentage points.",
                "category": "company",
                "datetime": 1788516370,
                "headline": "1 Healthcare Stock for Long-Term Investors and 2 We Ignore"
              },
              {
                "id": 141420277,
                "url": "https://finnhub.io/api/news?id=8dff4283f6da452e92865d7101fd6ffa7f2bdc63d99febe33fac804fc18f8255",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%; India is forecast to expand at 16.9%. Consumables account for 68% of sales and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, biomarker R&D, molecular diagnostics and laboratory automation. Key players include Thermo Fisher",
                "category": "company",
                "datetime": 1788515280,
                "headline": "Global Multiplex Assays Market 2026 Edition -  Consumables Dominate Multiplex Assays with 68% Market Share"
              },
              {
                "id": 141441613,
                "url": "https://finnhub.io/api/news?id=0420395470f5d97e8d00192422ff7418cf2f92bd8942a555a7faa8f8e47a043e",
                "image": "",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "CLSA  analyst Michael Luo   initiates coverage on Thermo Fisher Scientific (NYSE:TMO) with a Outperform rating and announces Price Target of $748.",
                "category": "company",
                "datetime": 1788451931,
                "headline": "CLSA Initiates Coverage On Thermo Fisher Scientific with Outperform Rating, Announces Price Target of $748"
              },
              {
                "id": 141403192,
                "url": "https://finnhub.io/api/news?id=222861cbe182e09bd124e5448a1086f89de7650eb4bc2e208436fb5e5363a845",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2193840462/image_2193840462.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "As legacy pharmaceutical models face structural challenges, targeting the underlying technology enablers of next-generation care offers a compelling approach for healthcare investors.",
                "category": "company",
                "datetime": 1788444600,
                "headline": "Why Moderna's Cancer Vaccine Matters To Investors"
              },
              {
                "id": 141397922,
                "url": "https://finnhub.io/api/news?id=73fa98e06527503066cea8ed06de0e1adee97cbfa1f61ab221ce2598fe4039a5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names ranging from Broadcom to Moderna that could reshape your portfolio positioning.",
                "category": "company",
                "datetime": 1788440746,
                "headline": "Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devon Energy, Moderna, Permian Resources, PG&E, Thermo Fisher, Viper Energy, and More"
              },
              {
                "id": 141379711,
                "url": "https://finnhub.io/api/news?id=c96effe9b68c1b2464b294b0917e8c8d5d42c3f16f2ee1d039a7fa7aed78a31e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "PacBio cut its 2026 revenue outlook as weaker instrument demand and a slower SPRQ-Nx transition raised the stakes for clinical adoption.",
                "category": "company",
                "datetime": 1788375300,
                "headline": "PACB Cuts 2026 Outlook as Clinical Adoption Faces Its Crucial Test"
              },
              {
                "id": 141379441,
                "url": "https://finnhub.io/api/news?id=62e773579e3a62df81afcdad4037a0fd886c9dbd055e0ac4c015a53682f0fe97",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The market is obsessed with a handful of hyperscalers, but the real story might be the thousands of customers you've never heard of.",
                "category": "company",
                "datetime": 1788369887,
                "headline": "Beyond The Cloud Giants: What Could Power NVIDIA Stock From Here?"
              },
              {
                "id": 141379713,
                "url": "https://finnhub.io/api/news?id=86e15f8323c03c1ac87c4de0202df6bd8977a871e3b91cae624801d8ffb2b26d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "MMSI's broad portfolio, R&D investments and WRAPSODY opportunity support growth, while tariffs, China pressure and competition remain risks.",
                "category": "company",
                "datetime": 1788366660,
                "headline": "Here's Why You Should Add Merit Medical Stock to Your Portfolio Now"
              },
              {
                "id": 141379714,
                "url": "https://finnhub.io/api/news?id=d961378e58675e5c52ee90553ab694c6aee0cf1040150d8b9e000742c4ca5c9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788366605,
                "headline": "Why Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report?"
              },
              {
                "id": 141379715,
                "url": "https://finnhub.io/api/news?id=2fd36efae43a9563f6f9269b884a90404cb97202438be101b33968a24fd368ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "GE HealthCare's Photonova Spectra gains CE Mark, expanding access to its Deep Silicon photon-counting CT technology across Europe and other CE markets.",
                "category": "company",
                "datetime": 1788364440,
                "headline": "GEHC Wins CE Mark for Photonova Spectra, Expands International Reach"
              },
              {
                "id": 141376581,
                "url": "https://finnhub.io/api/news?id=9992d821fba528b5b45956fff5e60e579842219077cc84c37eb06c67c78622e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Prestige Consumer Healthcare gains from acquisitions, e-commerce growth and strong cash flow, though currency swings and high debt remain key risks.",
                "category": "company",
                "datetime": 1788356280,
                "headline": "Is This the Right Time to Add PBH Stock to Your Portfolio?"
              },
              {
                "id": 141376488,
                "url": "https://finnhub.io/api/news?id=bc71decb0d41aee1a5c41713559438ff510e10a5a2a747b41fed7a33eec2a2a2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "MBody AI’s hardware-agnostic platform was shortlisted alongside CrowdStrike, Lenovo and CVS Health in a category recognizing real-world AI deploymentISFIYA, Israel and LAS VEGAS, Sept. 02, 2026 (GLOBE NEWSWIRE) -- MBody AI Ltd. (\"MBody AI\" or the \"Company\") (NASDAQ: MBAI) today announced that its MBody AI Orchestrator™ platform has been shortlisted for AI Deployment of the Year in The 2026 A.I. Awards. The awards program is run by The Cloud Awards. The category recognizes the most impactful and",
                "category": "company",
                "datetime": 1788356100,
                "headline": "MBody AI Orchestrator Named Finalist for AI Deployment of the Year"
              },
              {
                "id": 141376583,
                "url": "https://finnhub.io/api/news?id=f215b7e0a909c11c8e19dd5d0355aa5aab6bc883a61fcd8a21fb842812e12af4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "NASHVILLE, Tenn., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced participation in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” Conference taking place September 10th, 2026 in New York. Event: Lake Street Capital Markets 10th Annual Best Ideas Growth “BIG10” ConferenceWho: Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea JamesDate: Thursday, September 10, 2026Location: Metropolit",
                "category": "company",
                "datetime": 1788354000,
                "headline": "iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference"
              },
              {
                "id": 141376584,
                "url": "https://finnhub.io/api/news?id=24569b0d75a2ac40e8136db562d12f9de9ac4051edf1bb435e40f436f04a9a2d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Former Israeli Consulate Economic Affairs Officer in Dubai, Founder of Israel’s Economic Division in the UAE Following the Abraham Accords, and Arabic-Speaking IDF Intelligence Analyst to Drive Government and Sovereign Engagement Across the GCC as Quantum Cyber Advances Its Israel-to-U.S. Battlefield-Proven Defense Technology StrategyNorwalk, CT, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Quantum Cyber N.V. (Nasdaq: QUCY) (“Quantum Cyber” or the “Company”), a Nasdaq-listed autonomous defense technology",
                "category": "company",
                "datetime": 1788352200,
                "headline": "Quantum Cyber Appoints Tzvi Lev as Head of Sales, Middle East to Lead GCC Commercial Expansion of Its Autonomous Defense Platform"
              },
              {
                "id": 141376585,
                "url": "https://finnhub.io/api/news?id=323914a6aab244c46436fbc5e705d5ab656e998a732346d572925b8e2cabe6fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Revvity (RVTY) is back in focus after a recent Zacks upgrade to Rank #2, which reflects improved earnings expectations even as questions remain about growth momentum and rising competitive pressure. Over the past year Revvity’s share price return has been strong, with a 30 day share price return of 12.5%, a 90 day share price return of 25.25% and a year to date share price return of 28.98%, while the 1 year total shareholder return is 44.46%. This suggests that positive momentum has been...",
                "category": "company",
                "datetime": 1788350787,
                "headline": "Revvity (RVTY) Margins Story Faces A Valuation Test Following Its Zacks Upgrade"
              },
              {
                "id": 141376586,
                "url": "https://finnhub.io/api/news?id=4a30548438f007b9bac2518efe02f69f1d23ab5cc16b0e967ad2360b60441c35",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Neo Performance Materials Inc. (\"Neo\" or the \"Company\") (TSX: NEO) (OTCQX: NOPMF) today announced the closing of the previously announced transaction under which its wholly-owned subsidiary, Neo North Star Holdings LLC (\"NNSH\"), together with the other shareholders of NNSR Holdings Inc. (\"NNSR Holdings\"), transferred all outstanding shares of NNSR Holdings and Neo North Star Resources, Inc., a wholly owned subsidiary of NNSR Holdings, via merger of NNSR Holdings to Greenland Mines Ltd. (\"Greenla",
                "category": "company",
                "datetime": 1788350400,
                "headline": "Neo Completes Transfer of Sarfartoq Interest to Greenland Mines"
              },
              {
                "id": 141376587,
                "url": "https://finnhub.io/api/news?id=0d9b3f1fe51318a14ed100fbe92a88cf4ba04e22ec64d7644476628936a16939",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.",
                "category": "company",
                "datetime": 1788349463,
                "headline": "3 of Wall Street’s Favorite Stocks We Find Risky"
              },
              {
                "id": 141376588,
                "url": "https://finnhub.io/api/news?id=f26df76317e2dc0ebeabd77d8c47198467eb113e100aecb2434bfbb68e7d6a61",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ImExHS Ltd (ASX:IME) reports a 17% revenue increase to $16 million, with contracted ARR more than doubling to $4.4 million, setting the stage for FY26 guidance of up to $33.7 million in revenue.",
                "category": "company",
                "datetime": 1788343229,
                "headline": "ImExHS Ltd (ASX:IME) (H1 2026) Earnings Call Highlights: EBITDA Quadruples to $1. ..."
              },
              {
                "id": 141376589,
                "url": "https://finnhub.io/api/news?id=b91e2a79df9f49cf1f62c3e3b5d974d13d0783243f0dda5644f9f0c07ef69768",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "UK gilt yields are sitting at multi decade highs, which keeps many investors parked in cash or large caps. That hesitation can leave smaller high quality British stocks with solid fundamentals trading quietly in the background. For patient investors willing to look beyond the headlines, that quiet can be an entry point. This article highlights three under followed UK stocks from our quality screen that merit a closer look. The three stocks below are just a first cut from our High Quality...",
                "category": "company",
                "datetime": 1788340388,
                "headline": "Top 3 British Undervalued Stocks To Watch In September 2026"
              },
              {
                "id": 141372509,
                "url": "https://finnhub.io/api/news?id=fe39252280e118ff2fa8880a440babc7b5b782509ec2959aebf8fd673a741e95",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/186805810/image_186805810.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "GMO’s 13F portfolio jumps to ~$44B. See top holdings, key buys/sells, and rebalancing across tech, healthcare & financials—read the update now.",
                "category": "company",
                "datetime": 1788296759,
                "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q2 2026 Update"
              },
              {
                "id": 141373643,
                "url": "https://finnhub.io/api/news?id=586a7b0273e63c068b81acc8775f2c6ac9290074de64940276220f0e54d8f76b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
                "category": "company",
                "datetime": 1788294620,
                "headline": "3 Hyped Up  Stocks We Find Risky"
              },
              {
                "id": 141369923,
                "url": "https://finnhub.io/api/news?id=d20150bde1d5a8b91aad361c7db866908d6a8a048c96121942c0ec6ae89711ad",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.",
                "category": "company",
                "datetime": 1788290940,
                "headline": "TMO Stock Could Gain Following the Launch of EMPAD G2 Detector"
              },
              {
                "id": 141370258,
                "url": "https://finnhub.io/api/news?id=6545bb751ae949e0c7ab96f599e32d8cc54b53cc4e6e0674e3f677f9ceef0bf7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",
                "category": "company",
                "datetime": 1788282002,
                "headline": "What Makes Revvity (RVTY) a New Buy Stock"
              },
              {
                "id": 141373177,
                "url": "https://finnhub.io/api/news?id=ba91940c0a6f24c307fb63676cc0c7d9584ae8a4a40172c0a6d73cd1b79778df",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The company is evaluating an additional application for CyPath Lung that could complement CT imaging when monitoring lung cancer survivors for recurrence or new primary cancers. Key Investor TakeawaysbioAffinity Technologies (NASDAQ:BIAF) is advancing CyPath Lung for potential use in post-treatment lung cancer surveillance, expanding its focus beyond early detection.",
                "category": "company",
                "datetime": 1788278627,
                "headline": "bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance"
              },
              {
                "id": 141361936,
                "url": "https://finnhub.io/api/news?id=781b7f2d6a815acac15e5fb4362f9b55cd991070be84b68d508ac08002c8f38c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Robinhood upgraded, Uber initiated: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1788273410,
                "headline": "Robinhood upgraded, Uber initiated: Wall Street's top analyst calls"
              },
              {
                "id": 141373179,
                "url": "https://finnhub.io/api/news?id=400968679dcf3d44bae3bdca41fe68d10d3c7a9ae64e9689827962bb87e85abf",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Tempus AI (NASDAQ:TEM) shares rose 2. 7% in pre-market trading following analyst actions from Piper Sandler and Canaccord Genuity as investors assessed the company’s pending acquisition of Personalis.",
                "category": "company",
                "datetime": 1788273378,
                "headline": "Tempus AI shares rise 2.7% following analyst actions"
              },
              {
                "id": 141373180,
                "url": "https://finnhub.io/api/news?id=0e542d4c8a8c6e06f009ad9b761ecf10c5e1861b9e6fb7fe262f3774fc1c3200",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Myriad Genetics (NASDAQ:MYGN) shares fell 7. 1% in pre-market trading to $2.",
                "category": "company",
                "datetime": 1788271430,
                "headline": "Myriad Genetics shares fall 7.1% after Piper Sandler downgrade"
              },
              {
                "id": 141361453,
                "url": "https://finnhub.io/api/news?id=1b2d0893273c19249b32e9861712d29f964fda1427a1169cd61a26cc27728510",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., September 01, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET).",
                "category": "company",
                "datetime": 1788267600,
                "headline": "Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026"
              },
              {
                "id": 141361454,
                "url": "https://finnhub.io/api/news?id=ba4de773420c7be088c75e391f4ba801b098868a0ff72379a3cf950bc5c73dca",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Opportunities center on NGS, metagenomic profiling, portable field tests and cloud analytics, driven by viral outbreaks, precision agriculture, biosecurity and demand for early detection. Plant Virome Diagnostics Market Plant Virome Diagnostics Market Dublin, Sept. 01, 2026 (GLOBE NEWSWIRE) -- The \"Plant Virome Diagnostics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global plant virome diagnostics market is experiencing strong growth as agricultural producers, re",
                "category": "company",
                "datetime": 1788265260,
                "headline": "Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen"
              },
              {
                "id": 141360709,
                "url": "https://finnhub.io/api/news?id=284113dded2e69c8309aa5cc7745ede084e2d6232e3d3956df4c7ecf5be64890",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Nvidia was ARK’s biggest August purchase, with roughly 548,000 shares added during the month.",
                "category": "company",
                "datetime": 1788263670,
                "headline": "What Is Cathie Wood Buying Now? Nvidia, SpaceX And Crypto Stocks Led ARK’s August Trades – While Cutting These Growth Stocks"
              },
              {
                "id": 141361110,
                "url": "https://finnhub.io/api/news?id=d5ff30661b36ade78c981291fb8200bfdc2b3593b5b7a0f879ffc1bdf536d503",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Merck KGaA (NYSE:MRK) shares rose 1. 7% to €141.",
                "category": "company",
                "datetime": 1788263097,
                "headline": "Merck KGaA shares rise 1.7% after HSBC upgrades stock to Buy"
              },
              {
                "id": 141361462,
                "url": "https://finnhub.io/api/news?id=0a3677afc85ab4e670983a3012dfb1c6534a795da0378d93aa86df7267e2a62f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Despite a challenging market, the company realized over 14% of NAV in distributions and advanced AI initiatives, while navigating a dip in portfolio performance.",
                "category": "company",
                "datetime": 1788228055,
                "headline": "Partners Group Private Equity Ltd (LSE:PEY) (Q2 2026) Earnings Call Highlights: Strong ..."
              },
              {
                "id": 141361455,
                "url": "https://finnhub.io/api/news?id=76eedefd000e69c51d8dd08832b5cf504b0566ff29ec9a902273e5e6de09fc9a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) introduces the EMPAD G2 detector for high speed, high dynamic range 4D scanning transmission electron microscopy. The company launches Orbitrap Isora and Isora Pro Mass Spectrometers that integrate molecular level isotope ratio analysis. The new instruments target research in material science, environmental studies, geoscience, bioscience, and food authenticity. Consider looking at other stocks developing tools and infrastructure that support advanced...",
                "category": "company",
                "datetime": 1788221221,
                "headline": "Thermo Fisher Scientific (TMO) Unveils New Tools For Electron Microscopy And Isotope Analysis"
              },
              {
                "id": 141361469,
                "url": "https://finnhub.io/api/news?id=34e30cd031c810d63415f91661c6455830424a81e544234aa232e3fa4a773e73",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "By Mike Sheikh Cocrystal Pharma (NASDAQ: COCP) may look like another undercapitalized, clinical-stage biotech searching for its niche, and in need of a rescue, but there is more to this story than what meets the eye. Investors glancing at the stock chart may miss the signs of a strategic reset orchestrated by biotech legends, and miss […] The post Cocrystal Pharma: The Strategic Reset Investors May Be Missing appeared first on ExecEdge.",
                "category": "company",
                "datetime": 1788194343,
                "headline": "Cocrystal Pharma: The Strategic Reset Investors May Be Missing"
              },
              {
                "id": 141361456,
                "url": "https://finnhub.io/api/news?id=a642784b2b99771dfe3a4cfeb6fd6a8f96f2753b17175dc786af4437493dc262",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence that its strong growth trajectory has further room to run.",
                "category": "company",
                "datetime": 1788176864,
                "headline": "Is Thermo Fisher Scientific Stock Outperforming the Nasdaq?"
              },
              {
                "id": 141361457,
                "url": "https://finnhub.io/api/news?id=d7e87c02c471d4ece1732fb994e77d6f8cb5997d2150dcef47578e6a954376d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The \"Biological Computing Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global biological computing market is experiencing exponential growth, supported by advances in DNA sequencing, synthetic biology, genomics research and bioinformatics. The market is projected to increase from $2.21 billion in 2025 to $2.90 billion in 2026, representing a compound annual growth rate (CAGR) of 31.2%. Historical biological computing marke",
                "category": "company",
                "datetime": 1788167460,
                "headline": "Trends & Strategies in the $2.9 Billion Biological Computing Market, 2026-2035 - Featuring Profiles of Microsoft, IBM, and Thermo Fisher Scientific"
              },
              {
                "id": 141361464,
                "url": "https://finnhub.io/api/news?id=0638f86afa25249910f65ad49cba09f6cb1e9195782124ad45138abbf345210c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Glaukos (GKOS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787934626,
                "headline": "Glaukos (GKOS) Up 8% Since Last Earnings Report: Can It Continue?"
              },
              {
                "id": 141361470,
                "url": "https://finnhub.io/api/news?id=593b1c6ba021e66a2063619d82010a685cdc30f40b46527dfe757028e7b5dbc7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Natera recently announced a collaboration with Kupando Therapeutics to supply its Latitude tissue-free MRD assay for a Phase 1 immunotherapy trial in multiple skin cancers, expanding the use of its technology in oncology research. At the same time, Duquesne Family Office significantly increased its position in Natera, making the diagnostics company its largest healthcare holding and underscoring rising institutional interest in its MRD and medtech platform. Now we’ll explore how this...",
                "category": "company",
                "datetime": 1787846770,
                "headline": "How Investors May Respond To Natera (NTRA) New MRD Trial Deal And Duquesne Stake Expansion"
              },
              {
                "id": 141361463,
                "url": "https://finnhub.io/api/news?id=109defb116bde3c987c807ab00745d3fcd55cd36b2c6b957c0e774a87c85471e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "QuidelOrtho Corporation (Nasdaq: QDEL), a leading global provider of diagnostic solutions, has released episode 60 of its Science Bytes podcast, featuring highlights from the 2026 Association for Diagnostics and Laboratory Medicine (ADLM) Annual Conference.",
                "category": "company",
                "datetime": 1787839920,
                "headline": "Faster Answers, Better Decisions: ADLM 2026 Highlights"
              },
              {
                "id": 141330511,
                "url": "https://finnhub.io/api/news?id=f5914793ac85596956015b21a32a03c585d432329096a2ba397a67efe0e46aef",
                "image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.87% on an annualized basis producing an average annual return of 15.26%. Currently, Thermo Fisher Scientific has a market",
                "category": "company",
                "datetime": 1787761840,
                "headline": "Here's How Much $1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today"
              },
              {
                "id": 141361465,
                "url": "https://finnhub.io/api/news?id=c2575e111775dff5f596320a42d923c812b8cd718038dda705f7bc20bb2dbdd4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
                "category": "company",
                "datetime": 1787735953,
                "headline": "3 Unpopular Stocks We Find Risky"
              },
              {
                "id": 141323340,
                "url": "https://finnhub.io/api/news?id=086f3262638df573fb45205a3b3a72b809ad82570ca30648c34ff55b83f0c775",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Delta-Air-Lines-Jet-Overturns-At-Toronto.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Experts recommend Delta, Thermo Fisher, Target, and Interactive Brokers Group, Inc. due to strong earnings and guidance.",
                "category": "company",
                "datetime": 1787728265,
                "headline": "Delta Air, Target, Thermo Fisher Scientific And A Financial Stock On CNBC’s ‘Final Trades’"
              },
              {
                "id": 141361185,
                "url": "https://finnhub.io/api/news?id=4742b1dcb34b8cd149f0c6c130850489b3febb0b66b576d8d4ea74b2416b4af2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Its growth profile stands well above major sector peers.",
                "category": "company",
                "datetime": 1787689810,
                "headline": "Eli Lilly Is Pulling Away From the Rest of Healthcare"
              },
              {
                "id": 141361467,
                "url": "https://finnhub.io/api/news?id=c2f45fcce0d626cbf3969988a93813707db08ec61bc0d523d5273c37e0a8013b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.",
                "category": "company",
                "datetime": 1787676180,
                "headline": "Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?"
              },
              {
                "id": 141328530,
                "url": "https://finnhub.io/api/news?id=987bec09fcd486813ecb7d3a7687216add4739a533d76a32cbe7bc626b57e328",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks.",
                "category": "company",
                "datetime": 1787667600,
                "headline": "Should You Continue to Hold Labcorp Stock in Your Portfolio?"
              },
              {
                "id": 141320816,
                "url": "https://finnhub.io/api/news?id=5a789fb0d8ba6535166e2bf9715875a32999a1425aaa985e9e3a009fcb978408",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "CareDx, BrightSpring and PACS have been highlighted in this Industry Outlook article.",
                "category": "company",
                "datetime": 1787651580,
                "headline": "Zacks Industry Outlook CareDx, BrightSpring and PACS"
              },
              {
                "id": 141361458,
                "url": "https://finnhub.io/api/news?id=a29e893a1e34a91a65482b02674ef3acf7a84ba6207369160e30ce9b4511e9a9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Amgen, Thermo Fisher and PepsiCo headline today's research, with growth drivers, strategic moves and key risks in focus.",
                "category": "company",
                "datetime": 1787610840,
                "headline": "Top Research Reports for Amgen, Thermo Fisher & Pepsi"
              },
              {
                "id": 141361468,
                "url": "https://finnhub.io/api/news?id=9e160724c0bab07d91ead877912bee94565c056e4da72fc60983c60d4984b789",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "SpaceX, trading at 93 times next year’s estimated earnings, seems hardly the stock to unite both short-term-focused hedge-fund managers and more long-term-oriented mutual-fund managers.",
                "category": "company",
                "datetime": 1787578620,
                "headline": "There are 6 stocks that both hedge funds and mutual funds have as overweight — and SpaceX is one"
              },
              {
                "id": 141309202,
                "url": "https://finnhub.io/api/news?id=64dca95cbecb10e25587e1b04ef31b6887f8b6c89f2314e64cde9afd73704d4f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2291295850/image_2291295850.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "Treasury Secretary Scott Bessent could tap the Treasury's almost $1T General Account to help fund increased purchases of long-dated government bonds, CNBC reported.",
                "category": "company",
                "datetime": 1787572860,
                "headline": "Wall Street Lunch: Bessent Floats $1T Treasury Firepower"
              },
              {
                "id": 141361459,
                "url": "https://finnhub.io/api/news?id=dc4549d0116381a42226c79d82f358598b7ae16bbfdcf7e203e56da96fb9727b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Turnarounds in the healthcare sector do not all look the same. Some companies recover because management executes better, launches stronger products, and improves operations, while others do so because the industries they serve begin improving after prolonged downturns. Medtronic (NYSE:MDT) and Thermo Fisher Scientific (NYSE:TMO) are two of healthcare’s most closely watched recovery stories, but […]",
                "category": "company",
                "datetime": 1787529220,
                "headline": "Medtronic vs. Thermo Fisher: Which Healthcare Turnaround Offers More Upside?"
              },
              {
                "id": 141361460,
                "url": "https://finnhub.io/api/news?id=f3d5f57c7f64f7de7667476ae3bfec944836958895256225f46ba2352e82ec1a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Healthcare investors are often faced with a choice between companies that generate steady growth across diversified businesses and those positioned to benefit from improving industry conditions. Abbott Laboratories (NYSE:ABT) and Thermo Fisher Scientific (NYSE:TMO) represent those two approaches. Abbott (NYSE:ABT) continues to deliver broad-based growth across diagnostics, medical devices, and nutrition, while Thermo Fisher (NYSE:TMO) […]",
                "category": "company",
                "datetime": 1787528597,
                "headline": "Abbott vs. Thermo Fisher: Which is the Better Investment, Diversification or Recovery?"
              },
              {
                "id": 141361461,
                "url": "https://finnhub.io/api/news?id=ca77797a418186fa2f51d2cda0f6eb3ed3328790db942a52f2b42e1774e9d3e6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Healthcare investors looking for long-term growth don’t always have to choose between fast-growing companies and defensive businesses. Sometimes the more interesting decision is between two high-quality companies that are growing for entirely different reasons. Johnson & Johnson (NYSE:JNJ) continues to benefit from the breadth of its pharmaceutical and medical technology businesses, while Thermo Fisher’s (NYSE:TMO) […]",
                "category": "company",
                "datetime": 1787527923,
                "headline": "Johnson & Johnson vs. Thermo Fisher: Which Healthcare Growth Story Is More Durable?"
              },
              {
                "id": 141302750,
                "url": "https://finnhub.io/api/news?id=6572a92e3e41bdcd5edabcb05d4a978b7585b43adaaadc5c9d7187199fbb50a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific (TMO) is drawing investor attention after completing Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative. See our latest analysis for Thermo Fisher Scientific. The proteomics update arrives after a strong run in Thermo Fisher Scientific’s stock, with the share price at US$629.27 and a 30 day share price return of 19.53%, alongside a 1 year total shareholder return of 26.32% that...",
                "category": "company",
                "datetime": 1787414965,
                "headline": "Thermo Fisher Scientific (TMO) Could Be Fully Valued On Parkinsons Proteomics Progress"
              },
              {
                "id": 141302748,
                "url": "https://finnhub.io/api/news?id=6dc24ddc63a284560a6e135de26c28cab8b112bf858eb204f1d48a72a995f222",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The latest analyst work on Thermo Fisher Scientific includes a higher Fair Value Estimate that has moved from US$590.77 to US$631.42, a change of about 6.9% that feeds directly into refreshed price targets across coverage. This shift sits against a backdrop of mixed optimism and caution, as analysts weigh Q2 strength, sector updates through 2026, and the balance of growth ambition and execution risks. As you read on, you will see how this evolving narrative could shape the way you track...",
                "category": "company",
                "datetime": 1787407764,
                "headline": "Thermo Fisher Scientific (TMO) Stock Fair Value Rises After Q2 Strength And Analyst Revisions"
              },
              {
                "id": 141302749,
                "url": "https://finnhub.io/api/news?id=f91451998441d418cc2d9aa60636d8b22e4d0e55fe36b0b064b2e35c8431fe12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific stock has delivered a strong 26.3% return over the past year, yet the valuation checks suggest the shares are no longer an obvious bargain. The Discounted Cash Flow (DCF) estimate points to a level that is close to the current price, while market multiples lean richer. Over the past 12 months Thermo Fisher Scientific has returned 26.3%, which puts more pressure on today’s buyers to justify paying up at current levels. Participation in areas such as protein design...",
                "category": "company",
                "datetime": 1787404093,
                "headline": "Thermo Fisher (TMO) Stock Looks Fully Valued Following Its Microbiology Sale"
              },
              {
                "id": 141278739,
                "url": "https://finnhub.io/api/news?id=a5c947171d3000651ec7a3b3df3ccb64db3ec85dec18db10d5870739d886c511",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Agilent Technologies has a company-confirmed earnings report dropping after the close on August 26, and every operating lever heading into that date is pointing the same direction. Here is what retirement-focused investors need to understand before the bell rings.",
                "category": "company",
                "datetime": 1787324445,
                "headline": "Agilent Stock Has A Catalyst Coming On August 26 That Investors Should Not Ignore"
              },
              {
                "id": 141278418,
                "url": "https://finnhub.io/api/news?id=14fca526c0005a2e54535a057914bc5cc07c743197784d940f83e1cfc6ec3e95",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Former General Electric and Thermo Fisher Scientific counsel Jonas Svedlund will oversee the carrier’s legal and compliance functions.",
                "category": "company",
                "datetime": 1787310900,
                "headline": "XPO names chief legal officer"
              },
              {
                "id": 141278740,
                "url": "https://finnhub.io/api/news?id=4f593bb4d42bf16578459f9d70d79028fa76058867ca56c48c0a33c0ac12de5e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "BIO's 19.1% monthly rally is backed by digital PCR gains and steadier diagnostics, but weak Life Science demand and a rich valuation loom.",
                "category": "company",
                "datetime": 1787242980,
                "headline": "Bio-Rad Gains 19.1% in the Past Month: Can Its Momentum Keep Building?"
              },
              {
                "id": 141264457,
                "url": "https://finnhub.io/api/news?id=0f35252255458197d640a9a6e84e4d446dab53e84ac4b4f95fe5bd54531381f7",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/20/Paris--France---June-16--2023-Elon-Musk-.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "TMO",
                "summary": "Elon Musk said mRNA could fundamentally change disease treatment, turning medicine into a software problem.",
                "category": "company",
                "datetime": 1787213910,
                "headline": "Elon Musk Says mRNA Has ‘Tremendous’ Potential After Moderna, Merck Cancer Vaccine Breakthrough — MRNA Stock Falls Over 11% in Premarket (UPDATED)"
              },
              {
                "id": 141278737,
                "url": "https://finnhub.io/api/news?id=67621dd00d7b4422294b7c05c38a9ef3f25ba0e393e2e079e5179b2aacf01c1b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Opportunities span AI-driven protein design and structure prediction, precision therapeutics, engineered biologics and vaccines, synthetic biology, novel enzymes, high-throughput screening, and advanced computational modeling, with Asia-Pacific offering expansion potential. Protein Design and Engineering Market Protein Design and Engineering Market Dublin, Aug. 19, 2026 (GLOBE NEWSWIRE) -- The \"Protein Design and Engineering Market Global Report 2026\" has been added to ResearchAndMarkets.com's o",
                "category": "company",
                "datetime": 1787153280,
                "headline": "Protein Design & Engineering Market Global Report 2026: Evaluating AI Platforms, Rational Design, Directed Evolution, and Strategies of Lonza, Thermo Fisher, GenScript, and Charles River"
              },
              {
                "id": 141266867,
                "url": "https://finnhub.io/api/news?id=9ac04e066b2b89b0fc3c8cc452cb4f1eac98134d4dbc5dfd4c146140b24123fd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "ABT's Medical Devices growth is fueled by electrophysiology, expanding CGM adoption and a cardiovascular pipeline extending into 2029 and beyond.",
                "category": "company",
                "datetime": 1787152020,
                "headline": "Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst"
              },
              {
                "id": 141278732,
                "url": "https://finnhub.io/api/news?id=b7bd12285fc5ecb61151668efdbeab3c1061622131de396f1923e27a0e0a8acc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how research tools & consumables stocks fared in Q2, starting with Thermo Fisher (NYSE:TMO).",
                "category": "company",
                "datetime": 1787148122,
                "headline": "Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks"
              },
              {
                "id": 141250811,
                "url": "https://finnhub.io/api/news?id=9d71a11ac50f796cfd2586dab3cdda355e745abc81ec1890055606c493633591",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1787091773,
                "headline": "Tracking Al Gore's Generation Investment Management Portfolio - Q2 2026 Update"
              },
              {
                "id": 141278742,
                "url": "https://finnhub.io/api/news?id=e7e7f7a6a725027dd5628f6a57a2818d1e6e728af5250c3bf4fb2c6880f69905",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1787059293,
                "headline": "3 S&P 500 Stocks with Open Questions"
              },
              {
                "id": 141278747,
                "url": "https://finnhub.io/api/news?id=19646b206032bf733f37af72dbba753c73fa3124f090524d2a01763b53b3832d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "QuidelOrtho's 31.7% three-month rally meets resilient core growth and cost savings, but China weakness, lower guidance and high debt cloud further gains.",
                "category": "company",
                "datetime": 1786992360,
                "headline": "QDEL Rallies 31.7% in Three Months: Can the Stock Keep Climbing Higher?"
              },
              {
                "id": 141278733,
                "url": "https://finnhub.io/api/news?id=fe07e930497fb07ba5730dfb40d73545854ab6f703558684b2354123e3469ea6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Thermo Fisher Scientific has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.",
                "category": "company",
                "datetime": 1786980689,
                "headline": "Thermo Fisher Scientific Stock: Analyst Estimates & Ratings"
              },
              {
                "id": 141278743,
                "url": "https://finnhub.io/api/news?id=3751aa2c0478dc7677521e525f42a5578d2556842ca914766274eb193bbfdc4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "PTC Therapeutics (NASDAQ:PTCT) plans to acquire the ST-920 Fabry disease gene therapy asset through a competitive bankruptcy auction, positioning the company to add a potential one-time treatment to its rare disease portfolio while using its existing global commercial and regulatory infrastructure.",
                "category": "company",
                "datetime": 1786896114,
                "headline": "PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal"
              },
              {
                "id": 141230562,
                "url": "https://finnhub.io/api/news?id=4d092ebe3aa6f83822c04a961bb022d30ba76830344f6c5fdbe0e95de91c9b2a",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1786857318,
                "headline": "Thermo Fisher Scientific: Biopharma Recovery And Share Gains Support The Upside"
              },
              {
                "id": 141278744,
                "url": "https://finnhub.io/api/news?id=b64ebc7a931ed7df30857236214f868813c07be1b2f8ad028cf42d29626250f1",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
                "category": "company",
                "datetime": 1786837500,
                "headline": "3 Profitable Stocks We’re Skeptical Of"
              },
              {
                "id": 141218677,
                "url": "https://finnhub.io/api/news?id=652224e6eaeca65523b7fcc05076da4b572b7f65213dd09624d1398b823f11df",
                "image": "",
                "source": "SeekingAlpha",
                "related": "TMO",
                "summary": "",
                "category": "company",
                "datetime": 1786721166,
                "headline": "Danaher: 2027 Growth Reacceleration Should Drive Upside"
              },
              {
                "id": 141215052,
                "url": "https://finnhub.io/api/news?id=0176a51efbd17552a021ae81e4d6bc2b237153c9b5d85da75207c1b8fc338ef7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec’s global expansion Patrick S. Jones Patrick S. Jones, President of Thermo Fisher Scientific’s Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Envetec Sustainable Technologies Limited (Envetec), a leading sustainability innovator in clean technology for healthcare and life science",
                "category": "company",
                "datetime": 1786690800,
                "headline": "Envetec Appoints Patrick S. Jones as Independent Director"
              },
              {
                "id": 141208038,
                "url": "https://finnhub.io/api/news?id=c8bcf0ee43232416974e444c297c4000449109a83a8108cf766fba36d8db622a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "European private equity firm Astorg will run the business as an independent diagnostics company, led by former PerkinElmer CEO Dirk Bontridder.",
                "category": "company",
                "datetime": 1786619968,
                "headline": "Thermo Fisher closes $1.1B sale of microbiology unit to PE firm"
              },
              {
                "id": 141203650,
                "url": "https://finnhub.io/api/news?id=4d5de86f126d470d2f229dffe7444b62a75213e96f560786a24d960fae237ac4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LivaNova PLC recently reported second-quarter 2026 results showing sales rising to US$390.59 million and net income climbing to US$108.57 million, alongside higher earnings per share versus a year earlier. On the back of this performance, the company raised its 2026 constant-currency revenue growth guidance to a range of 8% to 9% and secured a long-term oxygenator supply agreement with Thermo Fisher Scientific to support manufacturing expansion. Now we’ll examine how the raised 2026 growth...",
                "category": "company",
                "datetime": 1786576597,
                "headline": "Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)"
              },
              {
                "id": 141203651,
                "url": "https://finnhub.io/api/news?id=c0c058b308c8596f720000900af5beb5fe1d492b5330e21eb98a5a6ef975c725",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record quarterly revenue and significantly higher profitability, supported by demand for its Essenz heart-lung machine and a new supply agreement with Thermo Fisher Scientific. See our latest analysis for LivaNova. LivaNova's recent guidance lift comes after a strong run in the share price, with a 90 day share price return of 12.71% and a year to date share price return of 33.21%. The 1 year total...",
                "category": "company",
                "datetime": 1786572592,
                "headline": "LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance"
              },
              {
                "id": 141200939,
                "url": "https://finnhub.io/api/news?id=bd785490179cd2145e424c9b579f44f31786f21fc5df1c0cef94108440c77c85",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "LUXEMBOURG & NEW YORK & PARIS, August 12, 2026--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026.",
                "category": "company",
                "datetime": 1786536600,
                "headline": "Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist"
              },
              {
                "id": 141200941,
                "url": "https://finnhub.io/api/news?id=b1f12e83ca42c474087a59f08c346969d87ef9b4ed4f0882dd05522ecd60ba3e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "WALTHAM, Mass., August 12, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.",
                "category": "company",
                "datetime": 1786536000,
                "headline": "Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg"
              },
              {
                "id": 141200944,
                "url": "https://finnhub.io/api/news?id=3b447c99f68999cfd97d10c962b5d5dac069cdcc6abea5f60eb2ceeaa87d2eb5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific’s Q2 2026 revenue beat, Hamamatsu Photonics’ launch of its dedicated Lasers & Fibers Business Unit, and BD’s $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This report provides an in-depth analysis of key technological advancements, regional market shares, and competitive strategies across the global biophotonics sector. Biophotonics Mark",
                "category": "company",
                "datetime": 1786533600,
                "headline": "Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030"
              },
              {
                "id": 141200942,
                "url": "https://finnhub.io/api/news?id=43ac900446deda61745614e800236fd050b4c546db7858fa9c2cd3757d1056b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "TMO",
                "summary": "Arcturus Therapeutics (NASDAQ:ARCT) is positioning its mRNA platform around two rare-disease programs targeting cystic fibrosis and ornithine transcarbamylase deficiency, while its vaccine business is intended to help support therapeutic development, President and CEO Joseph Payne said during a Cana",
                "category": "company",
                "datetime": 1786496653,
                "headline": "Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 6,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1.8,
            "source_article_count": 103,
            "discarded_article_count": 94
          },
          "sentimentPoints": 8
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.6,
        "grade": "一般",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.7,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": true,
            "vcp_score": 2.7,
            "vcp_reason": "波幅收縮(14.2%→6.9%)；跌縮量(近10日5日)；站上MA50；升放量(近10日2日)；Ready=Y；Confirm=Y",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1720760,
              "down_days": 6,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1615190,
              "avg_vol_20": 1659270,
              "avg_vol_30": 1720760,
              "range_pct_10": 0.06938111132168322,
              "range_pct_20": 0.10986848398103564,
              "range_pct_30": 0.14197635134996633,
              "up_expand_ok": true,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 2,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9386492015156094,
              "dist_to_20d_high": 0.057465208655332264,
              "down_shrink_days": 5,
              "breakout_level_20d": 647,
              "vcp_breakout_confirm": true,
              "contraction_ratio_10_30": 0.48868076029550445
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.7,
          "rsiKdjPoints": 1.6,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.8,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.8,
            "details": {
              "atrPct": 2.513741718642522,
              "turnoverUsdM": 1088.07806086261,
              "liquidityPoints": 0.8,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.TMO",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 579.1614,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2.5,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.2,
            "stop_loss_percent": 5,
            "take_profit_price": 646.2271,
            "target_multiplier": 1.9,
            "technical_strength": 1.88,
            "take_profit_percent": 6
          },
          "positionPoints": 1.8,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.027483437285044,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.TMO",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 78.57,
    "atr": {
      "atr": 15.3293,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.51
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "弱勢",
      "score": 4,
      "value": -9.48
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.224
    },
    "kdj": {
      "d": 32.78,
      "j": 39.74,
      "k": 35.1,
      "rule": "Cursor_18.24 K/D cross",
      "score": 4,
      "signal": "金叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "弱流入",
      "score": 4,
      "value": 44.22
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 4,
      "trend": "弱勢",
      "value": 24475761,
      "recentSlope": -111553.9,
      "previousSlope": 374470
    },
    "rsi": 38.57,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 631.024,
      "position": "SAR喺價上",
      "distancePct": 3.48,
      "previousTrend": "下降"
    },
    "ma50": 578.485,
    "macd": {
      "macd": 8.04030067910685,
      "trend": "中性偏多",
      "signal": 12.520827910267217,
      "histogram": -4.480527231160368
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 612.6416,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.06,
      "score": 6,
      "avgVolume": 1676068,
      "currentVolume": 1784261
    },
    "derived": {
      "ma20": 612.837,
      "ma50": 578.485,
      "prevClose": 603.18,
      "avgVolume10": 1646926,
      "avgVolume20": 1676068,
      "changePercent": 1.1,
      "avgVolumeForScore": 1676068
    },
    "ma_cross": {
      "ma20": 612.837,
      "ma50": 578.485,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 612.1405,
      "prevMa50": 576.5552,
      "spreadPct": 5.94,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 583.8442,
      "upper": 641.8298,
      "position": "中間"
    },
    "rsi_short": 51.72,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.06
    }
  }
}

{
  "close": 609.82,
  "volume": 1784261,
  "changePercent": 1.1
}